(Q50859540)

English

Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9798583

Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9798583

chronic myeloid leukemia

0 references

0 references

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9798583

author name string

A Gratwohl

1

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9798583

J Hermans

2

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9798583

J M Goldman

3

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9798583

E Carreras

5

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9798583

A Devergie

6

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9798583

F Frassoni

7

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9798583

G Gahrton

8

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9798583

H J Kolb

9

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9798583

D Niederwieser

10

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9798583

T Ruutu

11

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9798583

J P Vernant

12

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9798583

T de Witte

13

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9798583

J Apperley

14

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9798583

language of work or name

0 references

publication date

1 October 1998

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9798583

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9798583

352

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9798583

9134

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9798583

1087-1092

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9798583

Chronic myelogenous leukemia: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903030-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Philadelphia chromosome-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903030-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903030-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903030-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903030-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Disappearance of pH1-Positive Cells in Four Patients with Chronic Granulocytic Leukemia after Chemotherapy, Irradiation and Marrow Transplantation from an Identical Twin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903030-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903030-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone-marrow transplantation for chronic myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903030-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood and marrow transplantation activity in Europe 1995. European Group for Blood and Marrow Transplantation (EBMT)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903030-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone Marrow Transplantation for Patients with Chronic Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903030-X

7 January 2021

based on heuristic

inferred from DOI database lookup

European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903030-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903030-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903030-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Unrelated donor bone marrow transplantation for chronic myelogenous leukemia: a decision analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903030-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2898%2903030-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(98)03030-X

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9798583

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/9798583

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50859540&oldid=1400022575"